A growing number of studies have unveiled that HMGA2 is upregulated in varying cancers and mainly uses miRNAs as upstream targets to affect proliferation, migration, and invasion of multiple cancer cells, thus modulating cancer development (Gao et al., 2017; Zhao et al., 2018; Xia et al., 2021). Here, HMGA2 is linked to cancer.